XML 53 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Derivative Financial Instruments
6 Months Ended
Jun. 30, 2015
Derivative Financial Instruments [Abstract]  
Derivative Financial Instruments

NOTE 4. DERIVATIVE FINANCIAL INSTRUMENTS

In connection with its interest rate risk management strategy, the Company economically hedges a portion of the cost of its repurchase agreement funding by entering into derivatives and other hedging contracts. To date, we have entered into Eurodollar and T-Note futures contracts and interest rate swaptions, but may enter into other contracts in the future.  The Company has not elected hedging treatment under GAAP, and as such all gains or losses (realized and unrealized) on these instruments are reflected in earnings for all periods presented.

In addition, the Company utilizes TBA securities as a means of investing in and financing Agency RMBS or as a means of reducing its exposure to Agency RMBS, and not as a hedge. The Company accounts for TBA securities as derivative instruments if either the TBA securities do not settle in the shortest period of time possible or if the Company cannot assert that it is probable at inception and throughout the term of the TBA securities that it will take physical delivery of the Agency RMBS for a long position, or make delivery of the Agency RMBS for a short position, upon settlement of the trade.

Derivative Assets (Liability), at Fair Value

The table below summarizes fair value information about our derivative assets and liability as of June 30, 2015 and December 31, 2014.

(in thousands)
Derivative Instruments and Related AccountsBalance Sheet LocationJune 30, 2015December 31, 2014
Assets
Futures contracts - Margin posted to counterpartyRestricted cash$8,663$5,174
Payer swaptionsDerivative assets, at fair value651,217
$8,728$6,391
Liability
Payer swaptions - Margin posted by counterpartyOther liabilities$(207)$(1,364)

The tables below present information related to the Company’s Eurodollar and T-Note futures positions at June 30, 2015 and December 31, 2014.

($ in thousands)
June 30, 2015
AverageWeightedWeighted
ContractAverageAverage
NotionalEntryEffectiveOpen
Expiration YearAmount(2)RateRateEquity(1)
Eurodollar Futures Contracts
2015$900,0000.85%0.45%$(1,819)
2016900,0001.51%1.04%(4,189)
2017900,0002.31%1.81%(4,570)
2018900,0002.77%2.34%(3,887)
2019900,0002.56%2.61%124
Total / Weighted Average$900,0002.04%1.62%$(14,341)
Treasury Note Futures Contracts
September 2015 10 year T-Note futures
(Sep 2015 - Sep 2025 Hedge Period)$120,0002.15%2.07%$(1,011)

($ in thousands)
December 31, 2014
AverageWeightedWeighted
ContractAverageAverage
NotionalEntryEffectiveOpen
Expiration YearAmountRateRateEquity(1)
Eurodollar Futures Contracts
2015$650,0000.79%0.63%$(1,039)
2016800,0001.52%1.54%139
2017800,0002.36%2.23%(1,041)
2018800,0002.94%2.54%(2,361)
Total / Weighted Average$760,0001.88%1.73%$(4,302)

  • Open equity represents the cumulative gains (losses) recorded on open futures positions from inception.
  • Treasury Futures Contracts were valued at 126.17 at June 30, 2015. The nominal value of the short position was $151.4 million.

The table below presents information related to the Company’s interest rate swaption positions at June 30, 2015.

($ in thousands)
OptionUnderlying Swap
WeightedWeighted
AverageFixedReceiveAverage
FairMonths toNotionalPayRateTerm
ExpirationCostValueExpirationAmountRate(LIBOR)(Years)
June 30, 2015
≤ 1 year$3,200$652$175,0003.29%3 Month10
December 31, 2014
≤ 1 year$5,350$1,2176$375,0002.79%3 Month7.3

Gain (Loss) From Derivative Instruments, Net

The table below presents the effect of the Company’s derivative financial instruments on the statements of operations for the six and three months ended June 30, 2015 and 2014.

(in thousands)
Six Months Ended June 30,Three Months Ended June 30,
2015201420152014
Eurodollar futures contracts (short positions)$(10,960)$(6,136)$358$(4,599)
T-Note futures contracts (short position)(1,011)-(1,011)-
Payer swaptions(1,152)(1,285)(61)(1,129)
Net TBA securities(31)-(88)-
$(13,154)$(7,421)$(802)$(5,728)

Credit Risk-Related Contingent Features

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. We minimize this risk by limiting our counterparties for instruments which are not centrally cleared on a registered exchange to major financial institutions with acceptable credit ratings and monitoring positions with individual counterparties. In addition, we may be required to pledge assets as collateral for our derivatives, whose amounts vary over time based on the market value, notional amount and remaining term of the derivative contract. In the event of a default by a counterparty, we may not receive payments provided for under the terms of our derivative agreements, and may have difficulty obtaining our assets pledged as collateral for our derivatives. The cash and cash equivalents pledged as collateral for our derivative instruments are included in restricted cash on our balance sheets.